Lipidomic alterations in the cerebral cortex and white matter in sporadic Alzheimer's disease.

Non-targeted LC-MS/MS-based lipidomic analysis was conducted in post-mortem human grey matter frontal cortex area 8 (GM) and white matter of the frontal lobe centrum semi-ovale (WM) to identify lipidome fingerprints in middle-aged individuals with no neurofibrillary tangles and senile plaques, and c...

Descripción completa

Detalles Bibliográficos
Autores: Obis Monné, Èlia, Sol, Joaquim, Andrés Benito, Pol, Martín Garí, Meritxell, Mota Martorell, Natàlia, Galo-Licona, José Daniel, Piñol Ripoll, Gerard, Portero Otín, Manuel, Ferrer, Isidro, Jové Font, Mariona, Pamplona Gras, Reinald
Tipo de recurso: artículo
Estado:Versión publicada
Fecha de publicación:2023
País:España
Institución:Universitat de Lleida (UdL)
Repositorio:Repositori Obert UdL
OAI Identifier:oai:repositori.udl.cat:10459.1/465628
Acceso en línea:https://doi.org/10.14336/AD.2023.0217
https://hdl.handle.net/10459.1/465628
Access Level:acceso abierto
Palabra clave:Alzheimer disease
White matter
Grey matter
Lipidomics
Peroxisomal beta-oxidation
Lipid peroxidation
Descripción
Sumario:Non-targeted LC-MS/MS-based lipidomic analysis was conducted in post-mortem human grey matter frontal cortex area 8 (GM) and white matter of the frontal lobe centrum semi-ovale (WM) to identify lipidome fingerprints in middle-aged individuals with no neurofibrillary tangles and senile plaques, and cases at progressive stages of sporadic Alzheimer's disease (sAD). Complementary data were obtained using RT-qPCR and immunohistochemistry. The results showed that WM presents an adaptive lipid phenotype resistant to lipid peroxidation, characterized by a lower fatty acid unsaturation, peroxidizability index, and higher ether lipid content than the GM. Changes in the lipidomic profile are more marked in the WM than in GM in AD with disease progression. Four functional categories are associated with the different lipid classes affected in sAD: membrane structural composition, bioenergetics, antioxidant protection, and bioactive lipids, with deleterious consequences affecting both neurons and glial cells favoring disease progression.